HRAS and cancer: Meanwhile, HPV-positive and -negative tonsil cancers may likely have different preferences for cancer-related pathways and detailed somatic mutations: HPV-positive tumors tend to have higher rates of RB1, HRAS, and FGFR3 mutations.